forum bpc-157 user reports Should You Take Peptides? BPC-157: The Promise and Perils

It may reach immune and lining cells in a way that fits GI inflammation

TB-500 (and full T4) has a more developed preclinical cardiac evidence base than BPC-157, particularly in post-myocardial-infarction remodelling models, supported in part by NIH-funded investigation

This peptide has been utilized in preclinical studies examining growth factor receptor signaling, angiogenesis pathway activity, gut epithelial cell function, tendon and ligament cell models, and nitric oxide pathway interactions in controlled laboratory settings independent of the broader gastrointestinal effects associated with endogenous BPC activity

His aunt Sam wanted to call an ambulance but fumbled with her phone